EMEA-002351-PIP01-18

P/0089/2019: EMA decision of 22 March 2019 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for spartalizumab (EMEA-002351-PIP01-18)

AdoptedFirst published: 24/06/2019Reference Number: EMA/65170/2019

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

EMEA-002351-PIP01-18

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.